New Key Statistics Module, Z-Score and F-Score
NAS:LGND Key Ratios
Market Cap $ M | 1,263.73 |
Enterprise Value $ M | 1,099.59 |
P/E(ttm) | 24.27 |
PE Ratio without NRI | 20.42 |
Forward PE Ratio | 26.30 |
Price/Book | 1.76 |
Price/Sales | 9.49 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | 29.69 |
Payout Ratio % | -- |
Revenue (TTM) $ M | 131.00 |
EPS (TTM) $ | 2.90 |
Beneish M-Score | -2.24 |
10-y EBITDA Growth Rate % | 25.40 |
5-y EBITDA Growth Rate % | -21.10 |
y-y EBITDA Growth Rate % | 6.50 |
EV-to-EBIT | 17.10 |
EV-to-EBITDA | 11.00 |
PEG | -- |
Shares Outstanding M | 17.71 |
Net Margin (%) | 39.72 |
Operating Margin % | 7.48 |
Pre-tax Margin (%) | 48.48 |
Quick Ratio | 12.72 |
Current Ratio | 14.15 |
ROA % (ttm) | 6.71 |
ROE % (ttm) | 7.96 |
ROIC % (ttm) | 1.46 |
Dividend Yield % | -- |
Altman Z-Score | 10.45 |
LGND Number of Guru Trades
LGND Volume of Guru Trades
Gurus Latest Trades with NAS:LGND
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:LGND is held by these investors
Total 2
Ligand Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:LGND
Total 0- 1